Author:
Xie Jian-Fang,Wang Jia,Bai Huan-Huan,He Jiao-Jiao,Jia Rui-Huan,Wang Xia,Zhang Wen-Qi,Zhao Xiang-Cong,Zhang Xian-Cheng,Liu Guang-Ying,Li Xiao-Feng
Funder
the Key Research and Development Program of Shanxi Province
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference32 articles.
1. Wolfe F, Hawley DJ. The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients. J Rheumatol. 1998;25(11):2108–17.
2. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646–56.
3. Deane KD, Demoruelle MK, Kelmenson LB, et al. Genetic and environmental risk factors for rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2017;31(1):3–18.
4. Zhang SX, Wang J, Wang CH, et al. Low-dose IL-2 therapy limits the reduction in absolute numbers of circulating regulatory T cells in rheumatoid arthritis. Ther Adv Musculoskelet Dis. 2021. https://doi.org/10.1177/1759720X211011370.
5. He J, Zhang R, Shao M, et al. Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2020;79(1):141–9.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献